GLP-1RA 利拉古胺通过调节肠道微生物群和相关代谢物减轻败血症
Bing Gong1, Zhuang'e Shi1, Jialong Qi1
1Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Nutrients
|February 13, 2026
概括
类似葡萄糖类-1受体激动剂 (GLP-1RA) 利拉格卢提德通过调节肠道微生物群和增加素来改善败血症的存活率. 这种微生物代谢物显示出抗炎作用和作为败血症生物标志物的潜力.
科学领域:
- 微生物学和免疫学
- 胃肠病学和肝病学
- 药理学和药物发现
背景情况:
- 败血症引起的器官功能障碍是一个严重的未满足的临床需求,治疗选择有限.
- 类似葡萄糖-1受体激动剂 (GLP-1RAs) 正在成为潜在的治疗药物.
- 这项研究探讨了利拉格卢提德在败血症中的疗效,重点关注肠道微生物群-代谢相互作用.
研究的目的:
- 在毒症的小鼠模型中研究利拉格卢提德的治疗潜力.
- 阐明利拉格卢提德作用背后的机制,特别是其与肠道微生物群及其衍生代谢组的相互作用.
- 评估特定代谢物的作用,如素,在中介 liraglutide 的保护作用.
主要方法:
- 对公共转录组数据的分析,以确定利拉格卢提德和败血症之间的共同目标.
- 评估liraglutide对生存,炎症和器官损伤的影响在小鼠结和刺穿 (CLP) 模型中.
- 评估肠道微生物组成 (16S rRNA测序) 和便代谢组 (UPLC-MS),以及患者的血GLP-1测量;通过抗生素耗尽和便微生物移植 (FMT) 确认了微生物依赖性.
主要成果:
- 在败血症小鼠中,利拉格卢提德显著提高了生存率,并减少了全身炎症和器官损伤 (肺,肝脏,结肠).
- 利拉格卢提德部分逆转了败血症引起的肠道失调,并调节了关键代谢物,特别是增加了素水平.
- 利拉格卢提德的保护作用取决于肠道微生物群,如微生物群枯竭的小鼠中废除的益处和FMT所赋予的保护所证明;氨酸显示出直接的抗炎性质,与患者的败血症生物标志物相反相关.
结论:
- 利拉格卢提德通过调节肠道微生物群和相关代谢途径来减轻败血症的严重程度.
- 氨酸作为一种潜在的微生物调解剂以及肠道微生物群-宿主轴内的败血症的有希望的探索性生物标志物而出现.
- 需要进行进一步的研究,以充分阐明素和微生物群在利拉格卢提德治疗作用中的机械作用.
相关概念视频
Transcription Attenuation in Prokaryotes
18.6K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.6K
Attenuated Total Reflectance (ATR) Infrared Spectroscopy: Overview
1.3K
Attenuated total reflectance (ATR) infrared spectroscopy is a powerful analytical technique used to study the composition of materials. It is widely employed in chemistry, materials science, forensic science, and other fields where sample characterization is required. ATR has several advantages over traditional transmission IR spectroscopy, including the requirement of little to no sample preparation and the ability to analyze a wide range of samples.
The ATR process begins by directing a beam...
The ATR process begins by directing a beam...
1.3K
Physiology of Enteric Nervous System and Gut Health
1.0K
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
1.0K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
930
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
930
Riboswitches
9.8K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
9.8K


